D Hashim1, P Boffetta2, C La Vecchia3, M Rota4, P Bertuccio3, M Malvezzi5, E Negri4. 1. Institute of Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, USA dana.hashim@mssm.edu. 2. Institute of Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, USA. 3. Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan. 4. Department of Epidemiology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy. 5. Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan Department of Epidemiology, IRCCS-Istituto di Ricerche Farmacologiche 'Mario Negri', Milan, Italy.
Abstract
BACKGROUND: A decrease in cancer mortality has been reported in the United States, Europe, and other high-income regions during the last two decades. Whether similar trends apply to low-to-middle income countries-and globally-is unclear. DESIGN: The aim of this descriptive study is to compare cancer mortality in all countries with high- or intermediate-quality data on death certificates according to the World Health Organization (WHO) mortality database for the years 2000 through 2010. We included 60 countries in the analysis and calculated age-adjusted mortality rates for all cancer combined and for the commonest cancers worldwide: lung, stomach, breast, colorectal, uterine, and prostate. RESULTS: A decrease in overall cancer mortality rate of ∼1% per year was observed in higher and lower income regions and in both sexes. In 2010, 696 000 cancer deaths were avoided on a global scale compared with 2000 rates (426 000 in men, 271 000 in women). However, the mortality of liver cancer in both sexes and lung cancer in females increased in many countries'. CONCLUSIONS: The individual risk of dying from cancer decreased in all countries with reliable data. This decrease was chiefly due to favorable trends in the commonest specific cancers. Liver cancer in both sexes and lung cancer in women, which show increasing mortality rates, constitute a priority for prevention and further research.
BACKGROUND: A decrease in cancer mortality has been reported in the United States, Europe, and other high-income regions during the last two decades. Whether similar trends apply to low-to-middle income countries-and globally-is unclear. DESIGN: The aim of this descriptive study is to compare cancer mortality in all countries with high- or intermediate-quality data on death certificates according to the World Health Organization (WHO) mortality database for the years 2000 through 2010. We included 60 countries in the analysis and calculated age-adjusted mortality rates for all cancer combined and for the commonest cancers worldwide: lung, stomach, breast, colorectal, uterine, and prostate. RESULTS: A decrease in overall cancer mortality rate of ∼1% per year was observed in higher and lower income regions and in both sexes. In 2010, 696 000 cancer deaths were avoided on a global scale compared with 2000 rates (426 000 in men, 271 000 in women). However, the mortality of liver cancer in both sexes and lung cancer in females increased in many countries'. CONCLUSIONS: The individual risk of dying from cancer decreased in all countries with reliable data. This decrease was chiefly due to favorable trends in the commonest specific cancers. Liver cancer in both sexes and lung cancer in women, which show increasing mortality rates, constitute a priority for prevention and further research.
Authors: J Remon; D Isla; P Garrido; J de Castro; M Majem; N Viñolas; A Artal; E Carcereny; M R García-Campelo; P Lianes; M Provencio; O Juan; P Diz; R Blanco; R Lopez-Castro; I Maestu; C Vadell; E Felip Journal: Clin Transl Oncol Date: 2017-06-28 Impact factor: 3.405
Authors: Jane Turner; Patsy Yates; Lizbeth Kenny; Louisa G Gordon; Bryan Burmeister; Brett G M Hughes; Alexandra L McCarthy; Chris Perry; Raymond J Chan; Alana Paviour; Helen Skerman; Martin Batstone; Lisa Mackenzie Journal: Support Care Cancer Date: 2019-04-02 Impact factor: 3.603
Authors: I Blancas; M Fontanillas; V Conde; J Lao; E Martínez; M J Sotelo; A Jaen; J L Bayo; F Carabantes; J J Illarramendi; M M Gordon; J Cruz; A García-Palomo; C Mendiola; E Pérez-Ruiz; J S Bofill; J M Baena-Cañada; N M Jáñez; G Esquerdo; M Ruiz-Borrego Journal: Clin Transl Oncol Date: 2017-11-24 Impact factor: 3.405
Authors: Martina Chirra; Luca Marsili; Linsdey Wattley; Leonard L Sokol; Elizabeth Keeling; Simona Maule; Gabriele Sobrero; Carlo Alberto Artusi; Alberto Romagnolo; Maurizio Zibetti; Leonardo Lopiano; Alberto J Espay; Ahmed Z Obeidat; Aristide Merola Journal: Telemed J E Health Date: 2018-08-23 Impact factor: 3.536
Authors: Natalie C DuPré; Jaime E Hart; Michelle D Holmes; Elizabeth M Poole; Peter James; Peter Kraft; Francine Laden; Rulla M Tamimi Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-01-15 Impact factor: 4.254